| Rockwell Medical Commences PRIME Clinical Study; ESA Sparing Examined in ... - IEWY News |
|
|
IEWY News SFP is a novel, investigational, continuous iron therapy in late-stage clinical development, designed to treat iron deficiency anemia in ESRD patients. In contrast to intravenous (IV) iron delivery, SFP is a proprietary, water-soluble iron that travels |